J, Watson, K, Bryan, R, Williams, S, Popov, Vujanic, Gordan, A, Coulomb, L, Boccon-Gibod, N, Graf, K, Pritchard-Jones and M, O'Sullivan 2013. miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema. PLoS ONE 8 (1) , e53417. 10.1371/journal.pone.0053417 |
Abstract
The current SIOP treatment protocol for Wilms’ tumor involves pre-operative chemotherapy followed by nephrectomy. Not all patients benefit equally from such chemotherapy. The aim of this study was to generate a miRNA profile of chemo resistant blastemal cells in high risk Wilms’ tumors which might serve as predictive markers of therapeutic response at the pre-treatment biopsy stage. We have shown here that unsupervised hierarchical clustering of genome-wide miRNA expression profiles can clearly separate intermediate risk tumors from high risk tumors. A total of 29 miRNAs were significantly differentially expressed between post-treatment intermediate risk and high risk groups, including miRNAs that have been previously linked to chemo resistance in other cancer types. Furthermore, 7 of these 29 miRNAs were already at the pre-treatment biopsy stage differentially expressed between cases ultimately deemed intermediate risk compared to high risk. These miRNA alterations include down-regulation in high risk cases of miR-193a.5p, miR-27a and the up-regulation of miR-483.5p, miR-628.5p, miR-590.5p, miR-302a and miR-367. The demonstration of such miRNA markers at the pre-treatment biopsy stage could permit stratification of patients to more tailored treatment regimens.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) |
Publisher: | Public Library of Science |
ISSN: | 1932-6203 |
Date of Acceptance: | 28 November 2012 |
Last Modified: | 06 Jul 2023 01:41 |
URI: | https://orca.cardiff.ac.uk/id/eprint/110440 |
Citation Data
Cited 54 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |